← Back to the boardHill
FDA's draft guidance on early-phase IND protocol recommendations for solid tumors is open for public comment through January 12, 2027 under docket FDA-2026-D-13432.
Why it’s here: FDA draft guidance on early-phase IND protocols for solid tumor therapies is a federal regulatory action within the biotechnology area (FDA regulation of novel therapies), with an open comment period that industry and policy actors would engage.
Trace across the boardItem
11:59 PMAgencyFDAFDA's draft guidance on early-phase IND protocol recommendations for solid tumors is open for public comment through January 12, 2027 under docket FDA-2026-D-13432.Comment deadlineBiotechDetails1 linked
Connected
1 links- HillEarly-Phase IND Protocol Recommendations for Solid Tumors; Draft Guidance for Industry; AvailabilityBoth involve Food and Drug Administration, Early-Phase IND Protocol Recommendations for Solid Tumors
About
- Food and Drug Administration